lymphoma
Scope
Date
~
-
Bio & PharmaViGenCell, NK/T cell lymphoma treatment ‘VT-EBV-N’ designated as orphan drug in Europe
ViGenCell, a company specializing in immune cell therapy, announced on the 19th that its NK/T cell lymphoma treatment "VT-EBV-N" has been designated...
Dec 27, 2023 (Gmt+09:00)
-
Bio & PharmaVaxCell-Bio applies for approval of anti-cancer drug for dogs
South Korea’s VaxCell Biotherapeutics Co. (VaxCell-Bio) on Tuesday announced its application for approval for Vaxleukin-15, an anti-cancer dru...
Oct 24, 2023 (Gmt+09:00)
-
Bio & PharmaVerismo's CAR-T therapy designated fast-track status by FDA
Verismo Therapeutics, a US affiliate of South Korean pharmaceutical firm HLB Co., has received fast-track designation from the US Food and Drug Admi...
Apr 07, 2023 (Gmt+09:00)
-
Bio & PharmaGC Cell's AB-101 NK therapy achieves FDA fast-track status
South Korea's bio firm GC Cell announced on Wednesday that its US affiliate Artiva Biotherapeutics has received fast-track designation from the US F...
Feb 02, 2023 (Gmt+09:00)
Latest News
- 1 Lee Jae-myung to meet with top business leaders this week ahead of G7 summit
- 2 Korea to allow non-profits to buy bad consumer loans
- 3 LG to drive future growth in emerging markets with battery prowess
- 4 South Korean President Lee, Japanese Prime Minister Ishiba seek closer ties
- 5 Naver Ventures to plant flag in Silicon Valley with TwelveLabs bet
